244 related articles for article (PubMed ID: 25825487)
21. A KRAS GTPase K104Q Mutant Retains Downstream Signaling by Offsetting Defects in Regulation.
Yin G; Kistler S; George SD; Kuhlmann N; Garvey L; Huynh M; Bagni RK; Lammers M; Der CJ; Campbell SL
J Biol Chem; 2017 Mar; 292(11):4446-4456. PubMed ID: 28154176
[TBL] [Abstract][Full Text] [Related]
22. Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring.
Kopra K; Vuorinen E; Abreu-Blanco M; Wang Q; Eskonen V; Gillette W; Pulliainen AT; Holderfield M; Härmä H
Anal Chem; 2020 Apr; 92(7):4971-4979. PubMed ID: 32106676
[TBL] [Abstract][Full Text] [Related]
23. Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function.
Hocker HJ; Cho KJ; Chen CY; Rambahal N; Sagineedu SR; Shaari K; Stanslas J; Hancock JF; Gorfe AA
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10201-6. PubMed ID: 23737504
[TBL] [Abstract][Full Text] [Related]
24. Proteins regulating Ras and its relatives.
Boguski MS; McCormick F
Nature; 1993 Dec; 366(6456):643-54. PubMed ID: 8259209
[TBL] [Abstract][Full Text] [Related]
25. Control of ras activation.
Downward J
Cancer Surv; 1996; 27():87-100. PubMed ID: 8909796
[TBL] [Abstract][Full Text] [Related]
26. Superoxide inhibits guanine nucleotide exchange factor (GEF) action on Ras, but not on Rho, through desensitization of Ras to GEF.
Wey M; Phan V; Yepez G; Heo J
Biochemistry; 2014 Jan; 53(3):518-32. PubMed ID: 24422478
[TBL] [Abstract][Full Text] [Related]
27. Anthraquinones as Inhibitors of SOS RAS-GEF Activity.
Fernández-Medarde A; Fuentes-Mateos R; García-Navas R; Juan AO; Sánchez-López JM; Fernández-Medarde A; Santos E
Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439794
[TBL] [Abstract][Full Text] [Related]
28. Probing the GTPase cycle with real-time NMR: GAP and GEF activities in cell extracts.
Marshall CB; Meiri D; Smith MJ; Mazhab-Jafari MT; Gasmi-Seabrook GM; Rottapel R; Stambolic V; Ikura M
Methods; 2012 Aug; 57(4):473-85. PubMed ID: 22750304
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of free radical nitric oxide-mediated Ras guanine nucleotide dissociation.
Heo J; Prutzman KC; Mocanu V; Campbell SL
J Mol Biol; 2005 Mar; 346(5):1423-40. PubMed ID: 15713491
[TBL] [Abstract][Full Text] [Related]
30. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
31. High-Throughput Dual Screening Method for Ras Activities and Inhibitors.
Kopra K; van Adrichem AJ; Salo-Ahen OMH; Peltonen J; Wennerberg K; Härmä H
Anal Chem; 2017 Apr; 89(8):4508-4516. PubMed ID: 28318223
[TBL] [Abstract][Full Text] [Related]
32. Direct inhibition of oncogenic KRAS by Bacillus pumilus ribonuclease (binase).
Ilinskaya ON; Singh I; Dudkina E; Ulyanova V; Kayumov A; Barreto G
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1559-67. PubMed ID: 27066977
[TBL] [Abstract][Full Text] [Related]
33. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of Ras transforming activity.
Quilliam LA; Huff SY; Rabun KM; Wei W; Park W; Broek D; Der CJ
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8512-6. PubMed ID: 8078913
[TBL] [Abstract][Full Text] [Related]
34. Rasp21 sequences opposite the nucleotide binding pocket are required for GRF-mediated nucleotide release.
Leonardsen L; DeClue JE; Lybaek H; Lowy DR; Willumsen BM
Oncogene; 1996 Nov; 13(10):2177-87. PubMed ID: 8950985
[TBL] [Abstract][Full Text] [Related]
35. The GAP1 family of GTPase-activating proteins: spatial and temporal regulators of small GTPase signalling.
Yarwood S; Bouyoucef-Cherchalli D; Cullen PJ; Kupzig S
Biochem Soc Trans; 2006 Nov; 34(Pt 5):846-50. PubMed ID: 17052212
[TBL] [Abstract][Full Text] [Related]
36. Insulin and epidermal growth factor influence guanine nucleotide-releasing factor by distinct mechanisms.
Langlois WJ; Medh J; Leitner JW; Sasaoka T; Olefsky JM; Draznin B
Endocrinology; 1994 Dec; 135(6):2412-7. PubMed ID: 7988425
[TBL] [Abstract][Full Text] [Related]
37. Structure-function based design of small molecule inhibitors targeting Rho family GTPases.
Nassar N; Cancelas J; Zheng J; Williams DA; Zheng Y
Curr Top Med Chem; 2006; 6(11):1109-16. PubMed ID: 16842149
[TBL] [Abstract][Full Text] [Related]
38. Characterization and properties of dominant-negative mutants of the ras-specific guanine nucleotide exchange factor CDC25(Mm).
Vanoni M; Bertini R; Sacco E; Fontanella L; Rieppi M; Colombo S; Martegani E; Carrera V; Moroni A; Bizzarri C; Sabbatini V; Cattozzo M; Colagrande A; Alberghina L
J Biol Chem; 1999 Dec; 274(51):36656-62. PubMed ID: 10593969
[TBL] [Abstract][Full Text] [Related]
39. The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases.
García-Torres D; Fierke CA
J Biol Chem; 2019 Aug; 294(31):11793-11804. PubMed ID: 31197034
[TBL] [Abstract][Full Text] [Related]
40. Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles.
Liao TJ; Jang H; Fushman D; Nussinov R
Biophys J; 2018 Aug; 115(4):629-641. PubMed ID: 30097175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
